Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1993 11
1994 7
1995 7
1996 40
1997 43
1998 49
1999 62
2000 123
2001 119
2002 166
2003 209
2004 238
2005 265
2006 275
2007 340
2008 278
2009 274
2010 275
2011 269
2012 315
2013 320
2014 314
2015 263
2016 290
2017 278
2018 253
2019 256
2020 249
2021 285
2022 273
2023 281
2024 294
2025 119

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,164 results

Results by year

Filters applied: . Clear all
Page 1
Medications for Obesity: A Review.
Gudzune KA, Kushner RF. Gudzune KA, et al. JAMA. 2024 Aug 20;332(7):571-584. doi: 10.1001/jama.2024.10816. JAMA. 2024. PMID: 39037780 Review.
Centrally acting drugs, such as phentermine-topiramate and naltrexone-bupropion, regulate appetite in the brain and are associated with constipation in approximately 20% of patients, although the incidence of other adverse effects (eg, paresthesia, nausea) varies by medica …
Centrally acting drugs, such as phentermine-topiramate and naltrexone-bupropion, regulate appetite in the brain and are associated wi …
Tremor.
Louis ED. Louis ED. Continuum (Minneap Minn). 2019 Aug;25(4):959-975. doi: 10.1212/CON.0000000000000748. Continuum (Minneap Minn). 2019. PMID: 31356289 Review.
Risk of Autism after Prenatal Topiramate, Valproate, or Lamotrigine Exposure.
Hernández-Díaz S, Straub L, Bateman BT, Zhu Y, Mogun H, Wisner KL, Gray KJ, Lester B, McDougle CJ, DiCesare E, Pennell PB, Huybrechts KF. Hernández-Díaz S, et al. N Engl J Med. 2024 Mar 21;390(12):1069-1079. doi: 10.1056/NEJMoa2309359. N Engl J Med. 2024. PMID: 38507750 Free PMC article.
With restriction to children born to mothers with epilepsy, the incidence was 4.2% with no exposure to antiseizure medication (8815 children), 6.2% with exposure to topiramate (1030 children), 10.5% with exposure to valproate (800 children), and 4.1% with exposure to lamot …
With restriction to children born to mothers with epilepsy, the incidence was 4.2% with no exposure to antiseizure medication (8815 children …
Narrative Review of Topiramate: Clinical Uses and Pharmacological Considerations.
Pearl NZ, Babin CP, Catalano NT, Blake JC, Ahmadzadeh S, Shekoohi S, Kaye AD. Pearl NZ, et al. Adv Ther. 2023 Sep;40(9):3626-3638. doi: 10.1007/s12325-023-02586-y. Epub 2023 Jun 27. Adv Ther. 2023. PMID: 37368102 Review.
One drug that is now being used for a variety of conditions is topiramate. This is a narrative review that used PubMed, Google Scholar, MEDLINE, and ScienceDirect to review literature on the clinical and pharmacologic properties of topiramate. ...Topiramate i …
One drug that is now being used for a variety of conditions is topiramate. This is a narrative review that used PubMed, Google Schola …
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.
Burnette EM, Nieto SJ, Grodin EN, Meredith LR, Hurley B, Miotto K, Gillis AJ, Ray LA. Burnette EM, et al. Drugs. 2022 Feb;82(3):251-274. doi: 10.1007/s40265-021-01670-3. Epub 2022 Feb 8. Drugs. 2022. PMID: 35133639 Free PMC article. Review.
Pharmacotherapies discussed include: disulfiram, acamprosate, naltrexone, nalmefene, topiramate, gabapentin, varenicline, baclofen, sodium oxybate, aripiprazole, ondansetron, mifepristone, ibudilast, suvorexant, prazosin, doxazosin, N-acetylcysteine, GET73, ASP8062, ABT-43 …
Pharmacotherapies discussed include: disulfiram, acamprosate, naltrexone, nalmefene, topiramate, gabapentin, varenicline, baclofen, s …
The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis.
Lampl C, MaassenVanDenBrink A, Deligianni CI, Gil-Gouveia R, Jassal T, Sanchez-Del-Rio M, Reuter U, Uluduz D, Versijpt J, Zeraatkar D, Sacco S. Lampl C, et al. J Headache Pain. 2023 May 19;24(1):56. doi: 10.1186/s10194-023-01594-1. J Headache Pain. 2023. PMID: 37208596 Free PMC article.
We found high certainty evidence that monoclonal antibodies acting on the calcitonin gene related peptide or its receptor (CGRP(r)mAbs), gepants, and topiramate increase the proportion of patients who experience a 50% or more reduction in monthly migraine days, compared to …
We found high certainty evidence that monoclonal antibodies acting on the calcitonin gene related peptide or its receptor (CGRP(r)mAbs), gep …
Erenumab versus topiramate for the prevention of migraine - a randomised, double-blind, active-controlled phase 4 trial.
Reuter U, Ehrlich M, Gendolla A, Heinze A, Klatt J, Wen S, Hours-Zesiger P, Nickisch J, Sieder C, Hentschke C, Maier-Peuschel M. Reuter U, et al. Cephalalgia. 2022 Feb;42(2):108-118. doi: 10.1177/03331024211053571. Epub 2021 Nov 7. Cephalalgia. 2022. PMID: 34743579 Free PMC article. Clinical Trial.
Patients with 4 migraine days per month and naive to study drugs were randomly assigned (1:1) to either subcutaneous erenumab (70 or 140 mg/month) plus topiramate placebo (erenumab group) or oral topiramate at the individual dose with optimal efficacy (50-100 mg/day …
Patients with 4 migraine days per month and naive to study drugs were randomly assigned (1:1) to either subcutaneous erenumab (70 or 140 mg/ …
Should topiramate be initial therapy in the management of idiopathic intracranial hypertension?: A literature review.
Goyal A, Zarroli K. Goyal A, et al. Medicine (Baltimore). 2023 Oct 20;102(42):e35545. doi: 10.1097/MD.0000000000035545. Medicine (Baltimore). 2023. PMID: 37861536 Free PMC article. Review.
The safety profile of topiramate is comparable or superior to acetazolamide. To date, there are limited studies comparing topiramate to acetazolamide or other treatment modalities in IIH. ...However, the data supporting use of acetazolamide or topiramate is i …
The safety profile of topiramate is comparable or superior to acetazolamide. To date, there are limited studies comparing topirama …
Weight Loss Pharmacotherapy: Current and Future Therapies.
Jordan G, Young S, Alemán JO. Jordan G, et al. Gastrointest Endosc Clin N Am. 2024 Oct;34(4):591-608. doi: 10.1016/j.giec.2024.06.006. Gastrointest Endosc Clin N Am. 2024. PMID: 39277293 Review.
There are currently 5 Food and Drug Administration-approved medications for the treatment of obesity: orlistat, phentermine/topiramate, naltrexone/bupropion, liraglutide 3.0 mg, and semaglutide 2.4 mg. Surgical options such as bariatric surgery and endoscopic surgery induc …
There are currently 5 Food and Drug Administration-approved medications for the treatment of obesity: orlistat, phentermine/topiramate …
Management of Alternating Hemiplegia of Childhood: A Review.
Samanta D. Samanta D. Pediatr Neurol. 2020 Feb;103:12-20. doi: 10.1016/j.pediatrneurol.2019.10.003. Epub 2019 Nov 1. Pediatr Neurol. 2020. PMID: 31836335 Review.
Disease-modifying therapy of alternating hemiplegia of childhood does not exist, and several agents such as benzodiazepines, flunarizine, topiramate, ketogenic diet, triheptanoin, steroid, amantadine, memantine, aripiprazole, oral ATP, coenzyme Q, acetazolamide, dextrometh …
Disease-modifying therapy of alternating hemiplegia of childhood does not exist, and several agents such as benzodiazepines, flunarizine, …
6,164 results